{"disease":{"id":"acute-lymphoblastic-leukemia-with-appropriate-mutations","name":"acute lymphoblastic leukemia with appropriate mutations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05738538","title":"Expanded Access to Ziftomenib","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Kura Oncology, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}